You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Brain Amyloid

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hypertension Trial in Dallas (Standard Care, Intensive Treatment)

Active, not recruiting
  • Hypertension
  • Standard Care
  • Intensive Treatment
  • Dallas, Texas
    UT Southwestern Medical Center
Aug 11, 2022

Program to Identify Participants at High Risk for Amyloid

Not yet recruiting
  • Alzheimer's Disease
  • No Intervention
  • Lady Lake, Florida
  • +1 more
Sep 12, 2023

Normal Physiology Trial run by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) ([18F]florbetaben)

Completed
  • Normal Physiology
  • [18F]florbetaben
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 18, 2022

Alzheimer's Disease, Dementia With Lewy Bodies, Frontotemporal Dementia Trial in Rochester (Pittsburgh Compound B (C-11 PiB),

Enrolling by invitation
  • Alzheimer's Disease
  • +3 more
  • Pittsburgh Compound B (C-11 PiB)
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic
Sep 30, 2022

Multiple Sclerosis Trial in Pavia (18F-florbetaben PET/CT)

Recruiting
  • Multiple Sclerosis
  • 18F-florbetaben PET/CT
  • Pavia, PV, Italy
    ICS Maugeri SpA SB IRCCS
Mar 23, 2023

BEAM: Brain-Eye Amyloid Memory Study

Recruiting
  • Alzheimer's Disease
  • +4 more
  • Pittsburgh Compound B [11C]-PIB
  • Toronto, Ontario, Canada
  • +4 more
Oct 24, 2022

Alzheimer Trial in Berlin, Munich (DSPE-DOTA-Gd Liposomal Injection)

Recruiting
  • Alzheimer Disease
  • DSPE-DOTA-Gd Liposomal Injection
  • Berlin, Germany
  • +1 more
Jul 12, 2022

Pre-thrombolysis MRI Treated With Intravenous Thrombolysis

Recruiting
  • Hemorrhage
  • +2 more
  • None, pure observational study
  • Nimes, France
    CHU de Nîmes
Dec 5, 2022

Cognitively Normal Older Adults, Hypertension, Subjective Cognitive Decline Trial in Dallas (Angiotensin II Receptor Blockers

Recruiting
  • Cognitively Normal Older Adults
  • +3 more
  • Angiotensin II Receptor Blockers (ARBs, losartan) and Calcium Channel Blockers (CCB, amlodipine)
  • PCP
  • Dallas, Texas
    University of Texas Southwestern Medical Center
Dec 1, 2022

Imaging of Brain Structural/Functional Connectivity and Amyloid

Recruiting
  • Alzheimer Disease
  • F 18 T807 Flortaucipir
  • Saint Louis, Missouri
    Washington University School of Medicine
Sep 23, 2022

Late Onset Alzheimer Trial in New York (BAY 94-9172 (Florbetaben))

Active, not recruiting
  • Late Onset Alzheimer Disease
  • BAY 94-9172 (Florbetaben)
  • New York, New York
    Columbia University Medical Center
Feb 11, 2022

Alzheimer, Mild Cognitive Impairment Trial in Winston-Salem (low carbohydrate/high fat diet, low fat/high carbohydrate diet)

Recruiting
  • Alzheimer Disease
  • Mild Cognitive Impairment
  • low carbohydrate/high fat diet
  • low fat/high carbohydrate diet
  • Winston-Salem, North Carolina
    Wake Forest Baptist Medical Center
May 31, 2022

Tauopathies Trial in Philadelphia (Amyloid PET scan, Brain MRI Scan, Neurologic exam)

Recruiting
  • Tauopathies
  • Amyloid PET scan
  • +2 more
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Oct 14, 2023

Artificial Intelligence-based Computer Aided Diagnosis Software

Completed
  • Alzheimer Disease
  • Mild Cognitive Impairment
  • NeuroAI
  • Gwangju, Korea, Republic of
    Chonnam National University Hospital
Sep 14, 2022

Alzheimer's Disease (AD) and Related Disorders Trial in France (Flutemetamol (18F), Florbetapir (18F))

Completed
  • Alzheimer's Disease (AD) and Related Disorders
  • Flutemetamol (18F)
  • Florbetapir (18F)
  • Angers, France
  • +25 more
Feb 2, 2022

Tauopathies Trial in Philadelphia (drug, diagnostic test, behavioral)

Active, not recruiting
  • Tauopathies
  • 11C-HY-2-15 PET
  • +3 more
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Sep 6, 2023

Alzheimer's Disease Trial in Madison (icosapent ethyl (IPE), gel cap )

Active, not recruiting
  • Alzheimer's Disease
  • icosapent ethyl (IPE)
  • gel cap placebo
  • Madison, Wisconsin
    William S. Middleton Memorial Veterans Hospital, Madison, WI
Jul 23, 2021

Mild Cognitive Impairment Trial in Hong Kong

Withdrawn
  • Mild Cognitive Impairment
    • Hong Kong, Hong Kong
      The Chinese University of Hong Kong
    Oct 19, 2021

    Alzheimer, Cognitive Decline Trial in Dallas ([18F]AV-1451, Positron Emission Tomography)

    Completed
    • Alzheimer Disease
    • Cognitive Decline
    • Dallas, Texas
      UT Southwestern Medical Center
    Jul 28, 2022

    Eye to Brain Connection

    Not yet recruiting
    • Alzheimer Disease
      • (no location specified)
      Jan 18, 2022

      Cognitive Impairment, Mild, Cognitive Dysfunction, Amyloid Plaque Trial in Phoenix, Las Vegas (Lenalidomide 10 mg, Placebo)

      Recruiting
      • Cognitive Impairment, Mild
      • +4 more
      • Lenalidomide 10 mg
      • Placebo
      • Phoenix, Arizona
      • +1 more
      Apr 14, 2022

      Post-stroke Dementia, Vascular Mild Cognitive Impairment Trial in Taoyuan (THK-5351, AV-45)

      Completed
      • Post-stroke Dementia
      • Vascular Mild Cognitive Impairment
      • Taoyuan, Guishan, Taiwan
        Department of Neurology, Chang-Gung memorial Hospital
      Oct 3, 2021

      Amyloid-ß Clearance Mechanisms in Alzheimer's Disease

      Recruiting
      • Alzheimer's Disease (AD)
      • positron emission tomography (PET)
      • München, Bayern, Germany
        Klinik und Poliklinik für Psychiatrie und Psychotherapie des LMU
      Sep 16, 2021

      Alzheimer, Mild Cognitive Impairment Trial in Boston (Transcranial Alternating Current Stimulation (tACS), Sham Transcranial

      Recruiting
      • Alzheimer Disease
      • Mild Cognitive Impairment
      • Transcranial Alternating Current Stimulation (tACS)
      • Sham Transcranial Alternating Current Stimulation
      • Boston, Massachusetts
        Beth Israel Deaconess Medical Center
      Feb 2, 2022

      Optina Diagnostics' Cerebral ß-Amyloid Status (CAS) Test

      Not yet recruiting
      • Alzheimer Disease
      • +2 more
        • (no location specified)
        Nov 3, 2021